Key points are not available for this paper at this time.
MCF7 EDR Palbo-R cell line displays cross-resistance to two other CDK4/6 inhibitors, in addition to being palbociclib-resistant
Chen et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: